Applied DNA Sciences (APDN) Tops Q1 EPS by 18c
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 11/5/2026
- Nasdaq futures slip on chip weakness; S&P 500 holds gains
- What the Democratic sweep in the midterms means for markets
- SpaceX, Tesla slide as election risks mount, Morgan Stanley turns bullish
- CVS Health plans to split into two public companies by 2028
- AI sector outlook darkens as Democrat wins threaten $900B capex cycle
Tweet
Share
E-mailGet Alerts APDN Hot Sheet
Price: $5.62 --0%
Financial Fact:
Net loss before provision for income taxes: -2.42M
Today's EPS Names:
KEEL, SENEA, XFOR, More
Financial Fact:
Net loss before provision for income taxes: -2.42M
Today's EPS Names:
KEEL, SENEA, XFOR, More
Join SI Premium – FREE
Applied DNA Sciences (NASDAQ: APDN) reported Q1 EPS of ($0.09), $0.18 better than the analyst estimate of ($0.27). Revenue for the quarter came in at $890 thousand versus the consensus estimate of $776.11 thousand.
For earnings history and earnings-related data on Applied DNA Sciences (APDN) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Verisk Analytics (VRSK) Tops Q3 EPS by 3c; Offers Guidance
- Prestige Brands (PBH) Tops Q2 EPS by 5c; Offers Guidance
- Trulieve Cannabis Corp. (TRLV) Tops Q3 EPS by 1c
Create E-mail Alert Related Categories
EarningsRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
